Ginkgo Bioworks
DNA
DNA
125 hedge funds and large institutions have $9.18B invested in Ginkgo Bioworks in 2021 Q3 according to their latest regulatory filings, with 125 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
125
Holders Change
+125
Holders Change %
–
% of All Funds
2.2%
Holding in Top 10
12
Holding in Top 10 Change
+12
Holding in Top 10 Change %
%
% of All Funds
0.21%
New
125
Increased
–
Reduced
–
Closed
–
Calls
$40.1M
Puts
$20M
Net Calls
+$20.2M
Net Calls Change
+$20.2M
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CCM
126
Cinctive Capital Management
New York
| – | – | – | – |
|
|
PI
127
PEAK6 Investments
Chicago,
Illinois
| – | – | – | – |
|
|
XS
128
XR Securities
Chicago,
Illinois
| – | – | – | – |
|
|
MSU
129
Mizuho Securities USA
New York
| – | – | – | – |
|
|
CFGS
130
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
131
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
SFM
132
Soros Fund Management
New York
| – | – | – | – |
|
|
IHWM
133
Iron Horse Wealth Management
Johston,
Iowa
| $0 | 28 | +28 | New |
|